AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $652,809 | +0.9% | 53,685 | +4.2% | 0.00% | – |
| Q2 2023 | $647,117 | +401.6% | 51,522 | +319.7% | 0.00% | – |
| Q3 2022 | $129,000 | -99.0% | 12,277 | -99.1% | 0.00% | -100.0% |
| Q4 2019 | $13,519,000 | -38.3% | 1,388,035 | -49.2% | 0.01% | -41.7% |
| Q3 2019 | $21,924,000 | -37.5% | 2,733,637 | -2.7% | 0.01% | -36.8% |
| Q2 2019 | $35,062,000 | -16.2% | 2,809,428 | -8.7% | 0.02% | -13.6% |
| Q1 2019 | $41,835,000 | +42.4% | 3,076,110 | +0.3% | 0.02% | +22.2% |
| Q4 2018 | $29,369,000 | -30.6% | 3,065,606 | -12.4% | 0.02% | -14.3% |
| Q3 2018 | $42,302,000 | -32.9% | 3,498,881 | -13.3% | 0.02% | -34.4% |
| Q2 2018 | $63,033,000 | +11.2% | 4,035,433 | +7.1% | 0.03% | +10.3% |
| Q1 2018 | $56,661,000 | +5.9% | 3,767,389 | +1.3% | 0.03% | +11.5% |
| Q4 2017 | $53,515,000 | +7.1% | 3,718,899 | +12.3% | 0.03% | +8.3% |
| Q3 2017 | $49,951,000 | +163.0% | 3,312,400 | +75.6% | 0.02% | +166.7% |
| Q2 2017 | $18,995,000 | +41.2% | 1,886,300 | 0.0% | 0.01% | +28.6% |
| Q1 2017 | $13,449,000 | +43.5% | 1,886,300 | 0.0% | 0.01% | +40.0% |
| Q4 2016 | $9,375,000 | -35.7% | 1,886,300 | -4.2% | 0.01% | -37.5% |
| Q3 2016 | $14,574,000 | +35.5% | 1,969,500 | 0.0% | 0.01% | +33.3% |
| Q2 2016 | $10,753,000 | -35.4% | 1,969,500 | 0.0% | 0.01% | -33.3% |
| Q1 2016 | $16,642,000 | -12.9% | 1,969,500 | 0.0% | 0.01% | -10.0% |
| Q4 2015 | $19,104,000 | +13.2% | 1,969,500 | +63.3% | 0.01% | +25.0% |
| Q3 2015 | $16,871,000 | -34.0% | 1,205,900 | -33.3% | 0.01% | -33.3% |
| Q2 2015 | $25,575,000 | +20.3% | 1,807,400 | -7.5% | 0.01% | +20.0% |
| Q1 2015 | $21,264,000 | +30.8% | 1,954,400 | 0.0% | 0.01% | +42.9% |
| Q4 2014 | $16,261,000 | +45.9% | 1,954,400 | +4.3% | 0.01% | +40.0% |
| Q3 2014 | $11,145,000 | – | 1,873,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |